# Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care

> **NCT00324311** · PHASE3 · COMPLETED · sponsor: **MediWound Ltd** · enrollment: 182 (actual)

## Conditions studied

- Burn

## Interventions

- **DRUG:** DGD

## Key facts

- **NCT ID:** NCT00324311
- **Lead sponsor:** MediWound Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-10
- **Final completion:** 2010-02
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2011-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324311, "Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00324311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*